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Previous studies have shown that catecholamines increase the nerve growth factor (NGF) content in medium conditioned 
by mouse L-M fibroblast cells and mouse astroglial cells. In this study, the NGF mRNA levels in these cells were mea- 
sured by Northern blot analysis. In astroglial cells treated with epinephrine (EN), the cellular NGF mRNA level increased 
prior to accumulation of NGF in the culture medium. 3-Hydroxytyramine (DA) and norepinephrine (NE) also increased 
the cellular NGF mRNA content. An increased level of NGF mRNA elicited by EN was also observed in mouse L-M 
oells. These results indicate that catecholamines enhance NGF synthesis of L-M fibroblast cells and astroglial cells by 
in~easing the cellular content of NGF mRNA. The present results also indicate that the effects of cat~hola~nes are 
not mediated by adrenergic receptors. 
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1. INTRODUCTION 
Nerve growth factor (NGF) was initially de- 
scribed as a protein required for development and 
maintenance of sympathetic and sensory neurons 
in the peripheral nervous system (PNS) [ 11. Recent 
studies have also suggested important functions for 
NGF in the cholinergic neurons of the basal fore- 
brain in the central nervous system (CNS) [Z]. In 
previous reports, we showed that fibroblast cells 
cultured from mouse organs with sympathetic in- 
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nervation [3,4], an established cell line of mouse 
fibroblast cells [5], and astroglial cells cultured 
from mouse brain [6] synthesize and secrete NGF 
that is indistinguishable from mouse subrn~i~a~ 
gland @-NGF. Catecholamines cause a significant 
increase in the NGF content of the conditioned 
medium (CM) of fibroblast cells [5,7] and of astro- 
glial cells in the quiescent phase [8]. Catechol- 
amines do not affect viability of the cells, or their 
level of total protein synthesis [5,8]. The possibility 
that catecholamines uppress NGF degradation or 
stimulate NGF secretion may also be ruled out 
[S,S]. The accumulated data would suggest that 
catecholamines stimulate the de novo synthesis and 
secretion of NGF protein. In order to examine the 
de novo synthesis, Northern blot analysis of NGF 
mRNA was performed in this paper. 
2. MATERIALS AND METHODS 
2. I. Maternal 
Mouse submaxillary gland fl-NGF and anti&NGF antiserum 
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were prepared as in [9]. DMEM, FCS, and trypsin were ob- 
tained from Gibco; Medium 199, from Flow Labs; peptone, 
from Difco; tissue culture vessels, from Falcon; BSA, from Ar- 
mour; (-)-EN, DA, L-phenylephrine and salbutamol, from 
Sigma; (-)-NE, from Nakarai; 4-methylcatechol, from Tokyo 
Kasei; [y-“P]ATP (> 5000 Ci/mmol), [a-“P]dCTP (- 3000 
Ci/mmol) and multipriming labeling kit, from Amersham; 
AMV reverse transcriptase, from Life Science; dATP, dCTP, 
dGTP, TTP, and oligo(dT)-cellulose type 7, from Pharmacia; 
nick-translation kit, from Bethesda Research Labs; Td poly- 
nucleotide kinase and restriction enzymes, from Takara Shuzo; 
actin and c-myc probes, from Oncor; and nitrocellulose paper 
(0.45 pm, BA85), from Schleicher & Schuell. All other 
chemicals were reagent grade. 
2.2. Cell culture 
Mouse astroglial cells were cultured from the whole brain of 
newborn mice and maintained in DMEM containing 10% FCS 
as described [6]. The meninges of the brain were carefully 
removed. Cells were put into the quiescent phase by serum 
deprivation [lo]. Mouse L-M cells were obtained from the 
American Type Culture Collection and maintained as mono- 
layer cultures in Medium 199 supplemented with 0.5% peptone 
as in [5]. 
2.3. Preparation of hybridization probes 
Poly(A)+ RNA was isolated from the submaxillary glands of 
65-day-old male ICR mice according to Cathala et al. [l 11. A 
cDNA of length 341 bp covering almost the entire mouse ,!Y- 
NGF mature peptide was obtained from the poly(A)+ RNA, and 
the hybridization probe to detect NGF mRNA was prepared as 
described below. A synthetic oligonucleotide 30-mer, which was 
complementary to the sequences between amino acid residue 107 
and 116 [12], was used to prime specifically reverse transcription 
of the isolated submaxillary gland poly(A)+ RNA and a cDNA 
library was constructed [131. The 27-mer which was complemen- 
tary to the sequences between amino acid residues 28 and 36 [12] 
and the 30-mer mentioned above were kinased with [y-‘*P]ATP 
and Td polynucleotide kinase, and then used to screen the cDNA 
library [14]. A 341 bp long cDNA fragment, whose nucleotide 
sequence was in accord with nucleotides 641-982 (amino acid 
residues 3-l 16) of the reported mouse NGF sequence [12], was 
isolated and used to prepare the hybridization probe. A 32P- 
labeled single-stranded DNA was prepared by annealing the 
cloned 341 bp cDNA with the 30-mer and polymerizing an anti- 
sequence DNA with [a-‘sP]dCTP, dATP, dGTP, TTP and 
Klenow enzyme. Use of the “P-labeled probe thus obtained 
(primer extension method; spec. act. 2.8-7.1 x 10’ cmp/pg) 
resulted in a higher intensity of the hybridization image as com- 
pared with the probe labeled using the Amersham multipriming 
labeling system (random priming method; spec. act. 
1.2 x 10’ cpm/pg). Commercially obtained chicken actin DNA 
(770 bp) and human c-myc 3rd exon DNA (1800 bp) were nick- 
translated [15] to a specific activity of 4.5 x 10s and 
6.6 x 10’ cpm/pg, respectively, and used to detect he levels of 
actin mRNA or c-myc mRNA. 
2.4. Determination of NGF mRNA level 
For the determination of NGF mRNA, poly(A)+ RNAs were 
prepared [la] from cultured cells (about 2 x 10s cells). Poly(A)+ 
RNAs treated with 50% formamide were separated on 1% 
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agarose-formaldehyde gels, and then transferred onto nitro- 
cellulose filters. Hybridization with the “P-labeled probe (ap- 
prox. 4 x lo6 cpm/ml) was performed with 50% formamide at 
42°C for 24 h. After stringent washing, the filters were auto- 
radiographed at - 80°C for l-3 days with Kodak intensifying 
screens. The autoradiogram was scanned at a path width of 
0.8 mm (X-axis) with an LKB 2222 densitometer. 
2.5. Determination of NGF level 
For determination of NGF, the CM was directly applied to 
the EIA system [3,6]. The detection limit of the EIA with sub- 
maxillary gland NGF was 5 pg/ml [9]. The EIA system was not 
affected by the drugs or culture media used in this work. 
3. RESULTS 
As shown in fig.1, mouse L-M cells produced a 
moderately abundant quantity of NGF mRNA that 
was easily detectable in as little as 1 pg of total 
cellular poly(A)+ RNA. This mRNA was in- 
distinguishable from authentic NGF mRNA ex- 
tracted from mouse submaxillary gland regard- 
ing hybridization behavior and electrophoresis 
through agarose gels. The detection limit of this 
assay with submaxillary gland poly(A)+ RNA was 
0.1 ng/lane. The effect of 0.1 mM EN on the NGF 
mRNA level in mouse L-M cells was examined 
after 6 h exposure to EN, since EN is known to in- 
crease the NGF content of the CM after a lag time 
of 4 h, which remains elevated for 24 h [5]. As 
shown in fig. 1, the NGF mRNA level after 6 h was 
2.4-fold greater than the control level. 
Northern blot analysis on mouse astroglial cells 
showed the expression of a major 1.3 kb transcript 
which was identical in size to mouse submaxillary 
gland ,8 NGF mRNA (fig.2A). The effect of 
catecholaminases (0.15 mM EN, NE and DA) on 
the NGF mRNA level in astroglial cells was as- 
sessed after a few hours of incubation. EN and DA 
increased the NGF mRNA levels 5-7-fold (figs 
2A,3), the rise with NE being about 1.5-fold (not 
shown). These results agree with previous findings 
that EN and DA obviously increased the NGF con- 
tent in CM of astroglial cells, whereas NE did so 
but only slightly [9]. 
A time-course experiment revealed that the NGF 
content in the medium of control cultures increased 
in proportion to culture time, and the addition of 
0.15 mM EN accelerated this increase in NGF con- 
tent after a lag time of 4 h (fig.2B). Intracellular 
NGF contents were low and remained unchanged 
during the course of the experiment (not shown). 
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Fig.1. Northern blot analysis of poly(A)+ RNA from mouse 
submaxillary gland and mouse L-M cells. L-M cells were 
cultured in the presence or absence of 0.1 mM EN for 6 h. 
Poly(A)+ RNA (0.05-50 ng) extracted from mouse submax- 
illary gland and 1 fig L-M cell poly(A)+ RNA were analyzed by 
Northern blot hybridization as described in section 2. 
The NGF mRNA level in EN-treated astroglial cells 
increased 5.7-fold in 2,h, dropping to 1.7-fold over 
the normal level in 8 h (fig.ZA,B). Equal amounts 
of poly(A)+ RNA from each sample were then 
assayed for actin mRNA and c-myc mRNA. 
Fig.ZA shows that actin mRNA and c-myc mRNA 
were detected at nearly constant levels over the 
duration of the experiment. 
We previously suggested that the stimulatory ef- 
fects of catecholamines on NGF synthesis are due 
to the catechol part of the molecule [5,7], and are 
not mediated by adrenergic receptors [5]. In order 
to assess this possibility, we measured NGF mRNA 
levels after exposure of astroglial cells to phenyl- 
ephrine, an a-agonist or to salbutamol, a ,& 
agonist, which do not contain the catechol ring. As 
shown in fig.3, neither phenylephrine nor salbu- 
tamol increased the NGF mRNA level. We also in- 
vestigated the effect of 4-methylcatechol, a non- 
amine catechol, on the NGF mRNA level. Fig.4 
shows that treatment of L-M cells with 0.15 mM 
4-methylcatechol for 4 h increased the NGF 
mRNA level 2.1-fold. 4-Methylcatechol also in- 
creased the NGF mRNA level of astroglial cells 
8.1-fold. 
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Fig.2. Time course of the effects of 0.15 mM EN on cellular 
NGF mRNA and NGF levels in the medium of mouse astroglial 
cells. (A) Poly(A)+ RNA (1.5 cg) from astroglial cells treated 
with 0.15 mM EN for 0, 2, 4,8, 12 and 24 h (lanes 1-6, respec- 
tively) and 1 ng mouse submaxillary gland poly(A)+ RNA (lane 
C) were hybridized to “P-labeled NGF, actin, and c-myc cDNA 
probes. The filters were autoradiographed at - 80°C for 20 min 
(for determination of actin mRNA) of 2 days (for assay of NGF 
mRNA and c-myc mRNA). (B) NGF mRNA levels (s) are ex- 
pressed as fold increase over that in the absence of EN (mean f 
SE of 3 experiments). NGF levels with (0) or without EN (0) 
are expressed as ng per 100 mm dish. 
Fig.3. Effects of adrenergic agonists on the level of NGF mRNA 
in mouse astroglial cells. Poly(A)+ RNA (1.5 /cg) from untreated 
astroglial cells (lane 1) or from those treated with 0.15 mM DA 
(lane 2), phenylephrine (lane 3), or salbutamol (lane 4) for 3.5 h 
was analyzed by Northern blot analysis with “P-labeled NGF 
cDNA. Poly(A)+ RNA (1 ng) from mouse submaxillary gland 
was also analyzed (lane C). 
465 
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Fig.4. Effects of non-amine catechol on the level of NGF 
mRNA in mouse L-M and astroglial cells. Cells were treated 
with 0.15 mM 4-methylcatechol for 4 h. Samples (1.5 pg) of 
poly(A)+ RNA from control L-M cells (lane 1), 
4-methylcatechol-treated L-M cells (lane 2), control mouse 
astroglial cells (lane 3), and treated astroglial cells (lane 4) were 
electrophoresed, transferred to nitrocellulose and hybridized 
with a “P-labeled NGF probe. Poly(A)+ RNA (1 ng) from 
mouse submaxillary gland was also analyzed (lane C). 
4. DISCUSSION 
The present paper extends our previous reports 
that catecholamines markedly increase the NGF 
content in both fibroblast cells [5] and astroglial 
cells [8]. The present data reveal that catechol- 
amines increase the cellular concentration of NGF 
mRNA in both cells; namely, catecholamines in- 
crease the NGF concentration in CM primarily by 
increasing the cellular content of NGF mRNA. To 
assess the specificity of the effect of catechol- 
amines on the level of NGF mRNA, we determined 
actin mRNA and c-myc mRNA levels after ex- 
posure of astroglial cells to EN. The results in 
fig.2A indicate that the effects of catecholamines 
are specific for NGF mRNA. We previously 
demonstrated that catecholamines did not stimu- 
late incorporation of [3H]thymidine into astroglial 
cells, suggesting that catecholamines did not 
elevate NGF synthesis by initiating cell growth [B]. 
As the c-myc mRNA level is known to be cell- 
growth-dependent [ 171, the present findings that c- 
myc levels were not changed by EN are in accord 
with the previous suggestion. 
Our observations that neither phenylephrine nor 
salbutamol increased the NGF mRNA level where- 
as 4-methylcatechol did (figs 3,4) support our 
previous suggestion that the catechol part of the 
catecholamine molecule is necessary and that 
adrenergic receptors of cells do not participate in 
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the stimulatory effect of catecholamines on NGF 
synthesis [5,7]. 
The rapid time course of the effect of EN on 
NGF mRNA level (fig.2) suggests that catechol- 
amines increase the rate of transcription of the 
NGF gene [l&19]. Further work is necessary in 
order to differentiate between the possibility of 
transcriptional activation and that of posttransla- 
tional regulation by an increase in stability of the 
NGF mRNA. The question arises as to how many 
catecholamines activate the transcription of the 
NGF gene. To approach an answer, we have begun 
to identify the sequences of the NGF gene which 
are important for catecholamine action. 
It is of interest to determine whether the 
phenomena we observe in culture are evoked in 
vivo. It seems plausible that NE contributes, at 
least in part, to the regulation of the NGF mRNA 
level in the PNS, since (i) there is a positive correla- 
tion between the NGF mRNA level and NE content 
in the effector organs of sympathetic nerves [20]; 
(ii) the concentration of NE in the vicinity of sym- 
pathetic nerve terminals was estimated to be of the 
order of 10 000 pug/g [5]. We have begun to ex- 
amine the NGF and NGF mRNA levels in the PNS 
and CNS after administration of catecholamine 
analogues. 
It is also interesting to ascertain whether a 
catecholamine-sensitive s quence of the NGF gene 
exists in human genomic DNA. Clarification of 
this possibility will lead to a better understanding 
of the regulatory mechanism of NGF gene expres- 
sion and the pathogenesis of various degenerative 
nervous diseases, such as Alzheimer’s disease. 
Enhancement of the synthesis of endogeneous 
NGF by catecholamine analogues may become a 
promising therapy for various nervous diseases in 
the future. 
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